Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment
Dillman, R.O.; Hsieh, C. Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment. Biomedicines 2019, 7, 80. https://doi.org/10.3390/biomedicines7040080
Dillman RO, Hsieh C. Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment. Biomedicines. 2019; 7(4):80. https://doi.org/10.3390/biomedicines7040080
Chicago/Turabian StyleDillman, Robert O.; Hsieh, Candace. 2019. "Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment" Biomedicines 7, no. 4: 80. https://doi.org/10.3390/biomedicines7040080